Regional News Archives - Page 171 of 189 - Journal for Clinical Studies

Current Edition

Europe

Minoryx announces dosing of first US patient in phase 2/3 clinical study of min-102 (advance)

Mataró, Barcelona Spain – Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, today announces the dosing of its first US...

12 September 2018 Europe | news | North America | Regional News

Continue Reading →

Europe

FDA to review supplemental Biologics License Application for Praluent® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events

Paris and Tarrytown, NY - September 12, 2018 - Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted a su...

12 September 2018 Europe | news | North America | Regional News

Continue Reading →

news

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuxim...

5 September 2018 news | North America | Regional News

Continue Reading →

news

Multiple Sclerosis Drug Slows Brain Shrinkage

A new brain imaging clinical trial funded by the National Institutes of Health (NIH) has showed that multiple sclerosis drug ibudilast was better than a placebo at sl...

5 September 2018 news | North America | Regional News

Continue Reading →

news

Pfizer and Astellas amend clinical research protocols for two phase 3 trials of enzalutamide in patients with hormone-sensitive prostate cancer

Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced amendments to the protocols for two registr...

5 September 2018 news | North America | Regional News

Continue Reading →

Europe

Cannabis extract helps reset brain function in psychosis

Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with ...

5 September 2018 Europe | news | Regional News

Continue Reading →

Europe

Medicine24: the issue of infections in people who inject drugs

The Royal College of Physicians and Surgeons of Glasgow is to host a speaker at their flagship conference, Medicine24 who will talk about infections in people who inj...

5 September 2018 Europe | news | Regional News

Continue Reading →

news

Cleveland clinic-led trial shows unprecedented slowing in progressive multiple sclerosis

Sunday, September 2, 2018: A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland C...

5 September 2018 news | North America | Regional News

Continue Reading →

news

CRF Health Partners Innovative US Biotech with TrialMax® eCOA Solution for Phase III Prostate Oncology Study

Plymouth Meeting, PA – August 30, 2018: CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announ...

5 September 2018 news | North America | Regional News

Continue Reading →

Europe

Nanobiotix half year results for the six months ended June 30, 2018

Major milestones achieved with the success of Soft Tissue Sarcoma phase III clinical trial with first-in-class NBTXR3 product Overall expenses according to pla...

5 September 2018 Europe | news | Regional News

Continue Reading →